US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

57.18

+0.27000.47%

Post-market: 57.190.0062+0.01%19:59 EDT

Volume:27.57M

Turnover:1.57B

Market Cap:116.40B

PE:16.02

High:57.33

Open:57.00

Low:56.54

Close:56.91

52wk High:62.89

52wk Low:42.52

Shares:2.04B

Float Shares:2.03B

Volume Ratio:3.10

T/O Rate:1.36%

Dividend:2.50

Dividend Rate:4.37%

EPS(TTM):3.57

EPS(LYR):3.46

ROE:38.73%

ROA:10.69%

PB:5.80

PE(LYR):16.53

Loading ...

Overview Company News Filings

Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

Incyte blood cancer drug combo reduces disease-progression risk but with high side-effect rate

Bloomsbury Publishing (BMY) Receives a Buy from Deutsche Bank

Bristol-Myers Squibb Backs New Cell Therapy Combo in Early GI Cancer Trial

C4 Therapeutics jumps after Bristol Myers myeloma data

Jefferies Adjusts Price Target on Bristol-Myers Squibb to $73 From $70, Maintains Buy Rating

MT Newswires Live

Bristol Myers says CELMoD mezigdomide reduces risk of disease progression by 52%

Bristol-Myers Squibb Says Mezigdomide Combination Cuts Myeloma Progression Risk in Phase 3 Trial

MT Newswires Live

Bristol Myers Squibb Announces Celmod Mezigdomide Reduces Risk of Disease Progression or Death by More Than 50% VS. Standard of Care in Relapsed or Refractory Multiple Myeloma

THOMSON REUTERS

Bristol Myers Squibb: Mezikd Reduces Disease Progression/Death Risk by Over 50% VS Standard of Care in Relapsed or Refractory Multiple Myeloma

THOMSON REUTERS

Bristol Myers Squibb: Higher Overall Response Rate and Complete Response or Better Were Seen With Mezikd

THOMSON REUTERS

Bristol Myers Squibb: Safety Profile of Mezikd Was Consistent With Known Profile of Mezigdomide & Combination Regimen

THOMSON REUTERS

Bristol Myers Squibb: Significantly Improved Pfs Rates With Mezikd Across Patients in Second- & Third-Line and Those With Higher-Risk Disease

THOMSON REUTERS

Bristol Myers Squibb: Phase 3 Successor-2 Trial Shows Mezikd Achieves 18-Month Median Pfs

THOMSON REUTERS

Bristol Myers drug delays myeloma progression in hard to treat patients

Bristol-Myers Squibb: Hold Rating Reiterated as Analyst Maintains $61 Price Target Amid Near-Term Uncertainties and Long-Term Pipeline Potential

Bayer's Key Pharma Products Face Competitive Risk -- Market Talk

Capricor names Michael Maurer chief commercial officer

Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared To Competitors

Alto Neuroscience names Karuna Therapeutics founder Andrew Miller to board

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BMY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"Bristol-Myers Squibb","latestPrice":57.18,"timestamp":1780084800000,"preClose":56.91,"halted":0,"volume":27567487,"hourTrading":{"tag":"盘后","latestPrice":57.1862,"preClose":57.18,"latestTime":"19:59 EDT","volume":6589268,"amount":376767467.894958,"timestamp":1780099157921,"change":0.0062,"changeRate":0.000108,"amplitude":0.004022},"delay":0,"changeRate":0.004744333157617345,"floatShares":2031646263,"shares":2035753027,"eps":3.569767,"marketStatus":"Market Closed","change":0.27,"latestTime":"05-29 16:00:00 EDT","open":57,"high":57.33,"low":56.535,"amount":1573574294.652061,"amplitude":0.013969,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.569767,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780300800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":-18475200000,"exchange":"NYSE","adjPreClose":56.91,"dividendRate":0.043741,"preHourTrading":{"tag":"盘前","latestPrice":57,"preClose":56.91,"latestTime":"09:28 EDT","volume":5573,"amount":317354.908548,"timestamp":1780061300581,"change":0.09,"changeRate":0.001581,"amplitude":0.008737},"postHourTrading":{"tag":"盘后","latestPrice":57.1862,"preClose":57.18,"latestTime":"19:59 EDT","volume":6589268,"amount":376767467.894958,"timestamp":1780099157921,"change":0.0062,"changeRate":0.000108,"amplitude":0.004022},"volumeRatio":3.095647344586979,"optionData":{"bulkOrders":[{"symbol":"BMY","call":false,"expireDate":1780632000000,"strike":"55.0","timestamp":1780072040121,"price":0.36,"volume":2000,"amount":72000,"type":"+"}]},"impliedVol":0.2578,"impliedVolPercentile":0.0797},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","floatShares":2031646263,"roa":"10.69%","roe":"38.73%","lyrEps":3.46,"volumeRatio":3.095647344586979,"shares":2035753027,"dividePrice":2.5011,"high":57.33,"amplitude":0.013969,"preClose":56.91,"low":56.535,"week52Low":42.52,"pbRate":"5.80","psRate":"2.40","week52High":62.8864,"institutionHeld":0.7128,"latestPrice":57.18,"eps":3.569767,"divideRate":0.043741,"volume":27567487,"delay":0,"ttmEps":3.569767,"open":57,"prevYearClose":53.94,"prevWeekClose":59.46,"prevMonthClose":60.59,"prevQuarterClose":60.65,"fiveDayClose":59.55,"twentyDayClose":60.59,"sixtyDayClose":62.33,"dividendPayoutRate":0.7151007066521378,"dividendFrequency":"Q","dividendGrowthYears":4,"dividendGrowthRate":0.03333333333333337,"fiveYearAvgDividendRate":0.037305679384724975},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMY\",params:#limit:5,,,undefined,":[{"date":"2026-07-30","symbol":"BMY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785398400000,"name":null,"time":"Pre-Market","dateTimestamp":1785384000000,"actualEps":null},{"market":"US","date":"2026-04-30","symbol":"BMY","fiscalQuarterEnding":"2026/03","expectedEps":1.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"pre","actualEps":1.58},{"date":"2026-04-02","symbol":"BMY","amount":0.63,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-02","defaultRemindTime":1775136600000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-01","payableDate":"2026-04-02","currency":"USD","dateTimestamp":1775102400000,"payDate":"2026-05-01"},{"market":"US","date":"2026-02-05","symbol":"BMY","fiscalQuarterEnding":"2025/12","expectedEps":1.65,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1770267600000,"reportTimeType":"pre","actualEps":1.67},{"date":"2026-01-02","symbol":"BMY","amount":0.63,"announcedDate":"2025-12-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-02","defaultRemindTime":1767364200000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-02","payableDate":"2026-01-02","currency":"USD","dateTimestamp":1767330000000,"payDate":"2026-02-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMY\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-29","recordDate":"2016-07-01","paymentDate":"2016-08-01","value":0.38,"currency":"USD"},{"executeDate":"2016-10-05","recordDate":"2016-10-07","paymentDate":"2016-11-01","value":0.38,"currency":"USD"},{"executeDate":"2017-04-05","recordDate":"2017-04-07","paymentDate":"2017-05-01","value":0.39,"currency":"USD"},{"executeDate":"2017-07-05","recordDate":"2017-07-07","paymentDate":"2017-08-01","value":0.39,"currency":"USD"},{"executeDate":"2017-10-05","recordDate":"2017-10-06","paymentDate":"2017-11-01","value":0.39,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1563,"buy":0.1875,"hold":0.5938,"sell":0.0625,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5938,"analysts":32,"updateTime":1780027200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BMY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BMY","date":"2026-05-29","current":16.017852,"percent":0.477624,"low":-30.323822,"twenty":-15.759799,"median":16.310377,"eighty":22.403337,"high":27.240851,"avg":6.459815,"sd":18.751887,"marketCap":116214274666},"quantilePoints":[{"date":"2021-06-04","current":-23.315786,"twenty":13.183703,"median":39.110931,"eighty":64.853776,"marketCap":145000873449},{"date":"2021-06-11","current":-24.177472,"twenty":13.076111,"median":38.321748,"eighty":64.853776,"marketCap":150359698461},{"date":"2021-06-18","current":-23.865111,"twenty":12.918943,"median":37.341182,"eighty":64.853776,"marketCap":148417124394},{"date":"2021-06-25","current":-23.962051,"twenty":12.713253,"median":37.032625,"eighty":64.853776,"marketCap":149019992208},{"date":"2021-07-02","current":-24.037448,"twenty":12.656819,"median":36.735495,"eighty":64.853776,"marketCap":149488889397},{"date":"2021-07-09","current":-24.112846,"twenty":12.542371,"median":36.569788,"eighty":64.853776,"marketCap":149957786585},{"date":"2021-07-16","current":-24.163111,"twenty":12.276028,"median":36.398367,"eighty":64.853776,"marketCap":150270384711},{"date":"2021-07-23","current":-24.536508,"twenty":12.058207,"median":36.20409,"eighty":64.853776,"marketCap":152592542216},{"date":"2021-07-30","current":-29.693807,"twenty":11.96591,"median":36.009813,"eighty":61.057,"marketCap":150814846842},{"date":"2021-08-06","current":-29.803185,"twenty":-14.753585,"median":35.906961,"eighty":60.876911,"marketCap":151370375230},{"date":"2021-08-13","current":-29.536304,"twenty":-14.987324,"median":35.781252,"eighty":60.876911,"marketCap":150014885963},{"date":"2021-08-20","current":-30.275696,"twenty":-15.059273,"median":34.627419,"eighty":60.876911,"marketCap":153770257867},{"date":"2021-08-27","current":-29.138169,"twenty":-15.115938,"median":34.17561,"eighty":60.876911,"marketCap":147992762629},{"date":"2021-09-03","current":-28.705034,"twenty":-15.248154,"median":33.35279,"eighty":60.876911,"marketCap":145792870212},{"date":"2021-09-10","current":-27.62001,"twenty":-15.348311,"median":32.979745,"eighty":60.876911,"marketCap":140282028600},{"date":"2021-09-17","current":-26.823741,"twenty":-15.441509,"median":32.518541,"eighty":60.876911,"marketCap":136237781934},{"date":"2021-09-24","current":-26.35123,"twenty":-15.542928,"median":32.364263,"eighty":60.876911,"marketCap":133837899297},{"date":"2021-10-01","current":-26.036223,"twenty":-15.613954,"median":32.061419,"eighty":60.876911,"marketCap":132237977539},{"date":"2021-10-08","current":-25.051826,"twenty":-15.777999,"median":31.581441,"eighty":60.876911,"marketCap":127238222044},{"date":"2021-10-15","current":-25.533087,"twenty":-16.234944,"median":30.750116,"eighty":60.876911,"marketCap":129682546953},{"date":"2021-10-22","current":-25.200579,"twenty":-16.36727,"median":30.429194,"eighty":60.876911,"marketCap":127993740652},{"date":"2021-10-29","current":-23.982843,"twenty":-22.664495,"median":30.34167,"eighty":60.876911,"marketCap":129627264204},{"date":"2021-11-05","current":-24.414041,"twenty":-23.13914,"median":30.156897,"eighty":60.876911,"marketCap":131957891385},{"date":"2021-11-12","current":-24.405828,"twenty":-23.227463,"median":30.035336,"eighty":60.876911,"marketCap":131913498487},{"date":"2021-11-19","current":-23.748763,"twenty":-23.330148,"median":29.933224,"eighty":60.876911,"marketCap":128362066591},{"date":"2021-11-26","current":-23.214899,"twenty":-23.393674,"median":29.797076,"eighty":60.876911,"marketCap":125476528175},{"date":"2021-12-03","current":-23.128659,"twenty":-23.393674,"median":29.729002,"eighty":60.876911,"marketCap":125010402739},{"date":"2021-12-10","current":-23.145086,"twenty":-23.461298,"median":29.636615,"eighty":60.876911,"marketCap":125099188536},{"date":"2021-12-17","current":-25.280544,"twenty":-23.568548,"median":27.951968,"eighty":60.876911,"marketCap":136641342198},{"date":"2021-12-23","current":-25.48177,"twenty":-23.634806,"median":27.65765,"eighty":60.876911,"marketCap":137728968216},{"date":"2021-12-31","current":-25.60497,"twenty":-23.766579,"median":27.039995,"eighty":60.876911,"marketCap":138394861697},{"date":"2022-01-07","current":-25.802089,"twenty":-23.903887,"median":26.592299,"eighty":60.865513,"marketCap":139460291266},{"date":"2022-01-14","current":-26.664486,"twenty":-23.969949,"median":26.503175,"eighty":60.865513,"marketCap":144121545629},{"date":"2022-01-21","current":-26.093661,"twenty":-24.000827,"median":26.434777,"eighty":60.865513,"marketCap":141036239169},{"date":"2022-01-28","current":-26.656272,"twenty":-24.081403,"median":26.28969,"eighty":60.865513,"marketCap":144077152730},{"date":"2022-02-04","current":20.625497,"twenty":-24.122181,"median":26.107856,"eighty":60.865513,"marketCap":144254724325},{"date":"2022-02-11","current":20.843465,"twenty":-24.122181,"median":25.804687,"eighty":60.865513,"marketCap":145779193401},{"date":"2022-02-18","current":21.052274,"twenty":-24.122181,"median":24.80247,"eighty":60.865513,"marketCap":147239600991},{"date":"2022-02-25","current":21.441842,"twenty":-24.122181,"median":24.575651,"eighty":60.865513,"marketCap":149964242016},{"date":"2022-03-04","current":21.616368,"twenty":-24.122181,"median":24.306674,"eighty":60.865513,"marketCap":151184881195},{"date":"2022-03-11","current":21.463658,"twenty":-24.122181,"median":23.979644,"eighty":60.865513,"marketCap":150116821913},{"date":"2022-03-18","current":22.133715,"twenty":-24.122181,"median":23.933202,"eighty":60.865513,"marketCap":154803204476},{"date":"2022-03-25","current":22.26692,"twenty":-24.122181,"median":23.737758,"eighty":60.865513,"marketCap":155734841105},{"date":"2022-04-01","current":22.431005,"twenty":-24.122181,"median":23.392104,"eighty":60.865513,"marketCap":156882450469},{"date":"2022-04-08","current":23.631255,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":165277000447},{"date":"2022-04-14","current":23.552252,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":164724447790},{"date":"2022-04-22","current":23.017457,"twenty":-24.122181,"median":22.955165,"eighty":60.865513,"marketCap":160984091344},{"date":"2022-04-29","current":25.636645,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160254667678},{"date":"2022-05-06","current":26.113479,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":163235357657},{"date":"2022-05-13","current":25.817161,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":161383071741},{"date":"2022-05-20","current":25.949993,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162213406807},{"date":"2022-05-27","current":25.932963,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162106953593},{"date":"2022-06-03","current":25.602585,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160041761251},{"date":"2022-06-10","current":25.575338,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":159871436109},{"date":"2022-06-17","current":25.125751,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":157061071271},{"date":"2022-06-24","current":26.893443,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":168110914838},{"date":"2022-07-01","current":26.17138,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":163597298583},{"date":"2022-07-08","current":25.674111,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160488864747},{"date":"2022-07-15","current":25.766071,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161063712101},{"date":"2022-07-22","current":24.846463,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":155315238569},{"date":"2022-07-29","current":23.80824,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":157539125557},{"date":"2022-08-05","current":23.272571,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":153994601994},{"date":"2022-08-12","current":24.385859,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161361232290},{"date":"2022-08-19","current":24.308413,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160848771052},{"date":"2022-08-26","current":22.972467,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":152008814698},{"date":"2022-09-02","current":22.139921,"twenty":-24.131516,"median":22.294813,"eighty":60.876911,"marketCap":146499856390},{"date":"2022-09-09","current":22.640094,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":149809501885},{"date":"2022-09-16","current":23.078956,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":152713448900},{"date":"2022-09-23","current":22.817575,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":150983892222},{"date":"2022-09-30","current":22.940198,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":151795289182},{"date":"2022-10-07","current":22.491656,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":148827284512},{"date":"2022-10-14","current":22.788532,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":150791719257},{"date":"2022-10-21","current":23.301613,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":154186774959},{"date":"2022-10-28","current":25.54071,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":170535320356},{"date":"2022-11-04","current":26.188951,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174863627979},{"date":"2022-11-11","current":25.251495,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":168604229262},{"date":"2022-11-18","current":25.746817,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":171911500215},{"date":"2022-11-25","current":26.34187,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":175884664649},{"date":"2022-12-02","current":26.970165,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":180079793576},{"date":"2022-12-09","current":26.205573,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174974610226},{"date":"2022-12-16","current":24.430389,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":163121706273},{"date":"2022-12-23","current":24.23093,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":161789919312},{"date":"2022-12-30","current":23.918444,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":159703453073},{"date":"2023-01-06","current":24.267497,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":162034080255},{"date":"2023-01-13","current":24.104606,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160946454236},{"date":"2023-01-20","current":24.649794,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":164586671930},{"date":"2023-01-27","current":24.08466,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160813275540},{"date":"2023-02-03","current":26.118629,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":165252565410},{"date":"2023-02-10","current":25.329282,"twenty":-24.131516,"median":22.245911,"eighty":60.555486,"marketCap":160258364307},{"date":"2023-02-17","current":23.588424,"twenty":-24.131516,"median":22.245911,"eighty":60.138319,"marketCap":149243959795},{"date":"2023-02-24","current":23.279927,"twenty":-24.131516,"median":22.245911,"eighty":59.828291,"marketCap":147292098136},{"date":"2023-03-03","current":22.988016,"twenty":-24.131516,"median":22.245911,"eighty":59.303982,"marketCap":145445175275},{"date":"2023-03-10","current":21.79715,"twenty":-24.131516,"median":22.190955,"eighty":58.624659,"marketCap":137910569514},{"date":"2023-03-17","current":22.069158,"twenty":-24.131516,"median":22.143065,"eighty":57.674063,"marketCap":139631565816},{"date":"2023-03-24","current":22.499062,"twenty":-24.131516,"median":22.143065,"eighty":57.089646,"marketCap":142351566870},{"date":"2023-03-31","current":23.040928,"twenty":-24.122181,"median":22.147947,"eighty":56.818785,"marketCap":145779951237},{"date":"2023-04-06","current":23.210469,"twenty":-24.122181,"median":22.147947,"eighty":56.570827,"marketCap":146852635917},{"date":"2023-04-14","current":23.499685,"twenty":-24.131516,"median":22.143065,"eighty":54.708084,"marketCap":148682509782},{"date":"2023-04-21","current":23.114063,"twenty":-24.131516,"median":22.143065,"eighty":52.238402,"marketCap":146242677962},{"date":"2023-04-28","current":19.428023,"twenty":-24.131516,"median":22.133715,"eighty":43.587843,"marketCap":142038275000},{"date":"2023-05-05","current":19.201013,"twenty":-24.131516,"median":22.049255,"eighty":42.979111,"marketCap":140378605761},{"date":"2023-05-12","current":19.850434,"twenty":-24.131516,"median":21.75269,"eighty":40.909864,"marketCap":145126520293},{"date":"2023-05-19","current":18.879176,"twenty":-24.131516,"median":21.57897,"eighty":40.438819,"marketCap":138025656966},{"date":"2023-05-26","current":18.551592,"twenty":-24.131516,"median":21.441842,"eighty":40.037509,"marketCap":135630691229},{"date":"2023-06-02","current":18.586075,"twenty":-24.131516,"median":21.323413,"eighty":39.672401,"marketCap":135882792885},{"date":"2023-06-09","current":18.767108,"twenty":-24.131516,"median":21.067856,"eighty":39.30989,"marketCap":137206326582},{"date":"2023-06-16","current":18.583201,"twenty":-24.131516,"median":20.924495,"eighty":38.76535,"marketCap":135861784414},{"date":"2023-06-23","current":18.764234,"twenty":-24.14085,"median":20.774901,"eighty":37.956903,"marketCap":137185318111},{"date":"2023-06-30","current":18.390674,"twenty":-24.150185,"median":19.657906,"eighty":36.490198,"marketCap":134454216832},{"date":"2023-07-07","current":18.229755,"twenty":-24.150185,"median":19.568826,"eighty":35.727263,"marketCap":133277742434},{"date":"2023-07-14","current":17.896425,"twenty":-24.150185,"median":19.258484,"eighty":33.43663,"marketCap":130840759754},{"date":"2023-07-21","current":18.324582,"twenty":-24.15952,"median":19.11768,"eighty":31.771888,"marketCap":133971021990},{"date":"2023-07-28","current":15.932591,"twenty":-24.15952,"median":18.915095,"eighty":27.682522,"marketCap":126871220392},{"date":"2023-08-04","current":16.063766,"twenty":-24.15952,"median":18.814521,"eighty":27.240851,"marketCap":127915771852},{"date":"2023-08-11","current":16.079507,"twenty":-24.15952,"median":18.65504,"eighty":26.887057,"marketCap":128041118028},{"date":"2023-08-18","current":16.30513,"twenty":-24.15952,"median":18.600443,"eighty":26.661838,"marketCap":129837746540},{"date":"2023-08-25","current":16.076884,"twenty":-24.15952,"median":18.534351,"eighty":26.588154,"marketCap":128020226998},{"date":"2023-09-01","current":16.173954,"twenty":-24.15952,"median":18.403605,"eighty":26.567923,"marketCap":128793195079},{"date":"2023-09-08","current":15.733204,"twenty":-24.15952,"median":18.315962,"eighty":26.505248,"marketCap":125283502172},{"date":"2023-09-15","current":15.607275,"twenty":-24.15952,"median":17.92516,"eighty":26.451358,"marketCap":124280732770},{"date":"2023-09-22","current":15.499711,"twenty":-24.15952,"median":17.785793,"eighty":26.356016,"marketCap":123424200572},{"date":"2023-09-29","current":15.253101,"twenty":-24.15952,"median":17.14351,"eighty":26.308627,"marketCap":121460443826},{"date":"2023-10-06","current":14.801857,"twenty":-24.15952,"median":16.994886,"eighty":26.256528,"marketCap":117867186802},{"date":"2023-10-13","current":14.759881,"twenty":-24.15952,"median":16.912197,"eighty":26.215546,"marketCap":117532930335},{"date":"2023-10-20","current":14.817598,"twenty":-24.15952,"median":16.861517,"eighty":26.181912,"marketCap":117992532978},{"date":"2023-10-27","current":13.009187,"twenty":-24.15952,"median":16.75383,"eighty":26.13539,"marketCap":107781117593},{"date":"2023-11-03","current":12.557292,"twenty":-24.15952,"median":16.645066,"eighty":26.102322,"marketCap":104037163348},{"date":"2023-11-10","current":12.380463,"twenty":-24.15952,"median":16.606678,"eighty":26.050188,"marketCap":102572137774},{"date":"2023-11-17","current":12.486069,"twenty":-24.15952,"median":16.545514,"eighty":25.981328,"marketCap":103447083603},{"date":"2023-11-24","current":12.220826,"twenty":-24.15952,"median":16.468598,"eighty":25.948631,"marketCap":101249545241},{"date":"2023-12-01","current":12.1275,"twenty":-24.15952,"median":16.323182,"eighty":25.871656,"marketCap":100476337299},{"date":"2023-12-08","current":12.319064,"twenty":-24.15952,"median":16.284141,"eighty":25.822267,"marketCap":102063448338},{"date":"2023-12-15","current":12.640794,"twenty":-24.15952,"median":16.244457,"eighty":25.741743,"marketCap":104728980980},{"date":"2023-12-22","current":12.589219,"twenty":-24.15952,"median":16.206012,"eighty":25.671391,"marketCap":104301681854},{"date":"2023-12-29","current":12.579395,"twenty":-24.15952,"median":16.17133,"eighty":25.63392,"marketCap":104220291545},{"date":"2024-01-05","current":12.780784,"twenty":-24.15952,"median":16.126731,"eighty":25.574657,"marketCap":105888792893},{"date":"2024-01-12","current":12.3338,"twenty":-24.15952,"median":16.052442,"eighty":25.53878,"marketCap":102185533803},{"date":"2024-01-19","current":12.301873,"twenty":-24.15952,"median":15.981387,"eighty":25.384604,"marketCap":101921015296},{"date":"2024-01-26","current":12.183987,"twenty":-24.15952,"median":15.915318,"eighty":25.326357,"marketCap":100944331580},{"date":"2024-02-02","current":11.953127,"twenty":-24.15952,"median":15.848219,"eighty":25.326357,"marketCap":99031659303},{"date":"2024-02-09","current":12.350536,"twenty":-24.15952,"median":15.711339,"eighty":25.326357,"marketCap":99113049612},{"date":"2024-02-16","current":12.458223,"twenty":-24.15952,"median":15.581954,"eighty":25.326357,"marketCap":99977242239},{"date":"2024-02-23","current":12.934478,"twenty":-24.15952,"median":15.510205,"eighty":25.326357,"marketCap":103799187786},{"date":"2024-03-01","current":12.788326,"twenty":-24.15952,"median":15.476991,"eighty":25.323432,"marketCap":102626315608},{"date":"2024-03-08","current":13.425852,"twenty":-24.15952,"median":15.421006,"eighty":25.323432,"marketCap":107742464938},{"date":"2024-03-15","current":13.226783,"twenty":-24.15952,"median":15.29517,"eighty":25.323432,"marketCap":106144932143},{"date":"2024-03-22","current":12.999995,"twenty":-24.15952,"median":15.228111,"eighty":25.323432,"marketCap":104324958073},{"date":"2024-03-28","current":13.418293,"twenty":-24.15952,"median":15.187513,"eighty":25.323432,"marketCap":107681799135},{"date":"2024-04-05","current":12.981358,"twenty":-24.15952,"median":15.120443,"eighty":25.326357,"marketCap":104175397951},{"date":"2024-04-12","current":12.405531,"twenty":-24.15952,"median":15.050664,"eighty":25.326357,"marketCap":99554388080},{"date":"2024-04-19","current":12.198436,"twenty":-24.15952,"median":15.01354,"eighty":25.326357,"marketCap":97892445934},{"date":"2024-04-26","current":-14.73835,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":90611374291},{"date":"2024-05-03","current":-14.408633,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":88584274195},{"date":"2024-05-10","current":-14.751538,"twenty":-24.15952,"median":14.897686,"eighty":25.323432,"marketCap":90692458295},{"date":"2024-05-17","current":-14.543817,"twenty":-24.15952,"median":14.883186,"eighty":25.323432,"marketCap":89415385234},{"date":"2024-05-24","current":-13.696444,"twenty":-24.15952,"median":14.851704,"eighty":25.323432,"marketCap":84205737987},{"date":"2024-05-31","current":-13.271109,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":81590778864},{"date":"2024-06-07","current":-13.478831,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":82867851924},{"date":"2024-06-14","current":-13.676661,"twenty":-24.15952,"median":14.80891,"eighty":25.326357,"marketCap":84084111982},{"date":"2024-06-21","current":-13.531586,"twenty":-24.15952,"median":14.706868,"eighty":25.329282,"marketCap":83192187939},{"date":"2024-06-28","current":-13.686553,"twenty":-24.161675,"median":14.733375,"eighty":25.346437,"marketCap":84144924984},{"date":"2024-07-05","current":-13.208463,"twenty":-24.161675,"median":14.649759,"eighty":25.346437,"marketCap":81205629845},{"date":"2024-07-12","current":-13.435968,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82604328912},{"date":"2024-07-15","current":-13.34035,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82016469884},{"date":"2024-08-02","current":-14.930382,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97659625724},{"date":"2024-08-09","current":-14.521245,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":94983464089},{"date":"2024-08-16","current":-15.221736,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99565377191},{"date":"2024-08-23","current":-14.759908,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":96544558376},{"date":"2024-08-30","current":-15.410807,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100802088250},{"date":"2024-09-06","current":-15.435603,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100964279864},{"date":"2024-09-13","current":-14.952078,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97801543386},{"date":"2024-09-20","current":-15.193841,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99382911625},{"date":"2024-09-27","current":-15.534788,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":101613046321},{"date":"2024-10-04","current":-16.799391,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":109884818647},{"date":"2024-10-11","current":-16.241478,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":106235507327},{"date":"2024-10-18","current":-16.48324,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107816875566},{"date":"2024-10-25","current":-16.402653,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107289752819},{"date":"2024-10-31","current":-16.322065,"twenty":-24.197578,"median":14.812351,"eighty":25.39607,"marketCap":106762630073},{"date":"2024-11-08","current":-15.288171,"twenty":-24.199732,"median":13.697044,"eighty":25.3977,"marketCap":110961545834},{"date":"2024-11-15","current":-16.347249,"twenty":-24.199732,"median":13.400607,"eighty":25.3977,"marketCap":118648335429},{"date":"2024-11-22","current":-16.2718,"twenty":-24.199732,"median":13.207884,"eighty":25.3977,"marketCap":118100727727},{"date":"2024-11-29","current":-16.548446,"twenty":-24.199732,"median":13.07937,"eighty":25.3977,"marketCap":120108622634},{"date":"2024-12-06","current":-16.442259,"twenty":-24.199732,"median":13.01341,"eighty":25.3977,"marketCap":119337915498},{"date":"2024-12-13","current":-15.726892,"twenty":-24.199732,"median":12.968664,"eighty":25.320507,"marketCap":114145783212},{"date":"2024-12-20","current":-15.732481,"twenty":-24.199732,"median":12.88985,"eighty":25.094333,"marketCap":114186346746},{"date":"2024-12-27","current":-16.207529,"twenty":-24.199732,"median":12.836673,"eighty":24.91965,"marketCap":117634247092},{"date":"2025-01-03","current":-15.869407,"twenty":-24.199732,"median":12.825525,"eighty":24.830114,"marketCap":115180153316},{"date":"2025-01-10","current":-15.874995,"twenty":-24.201887,"median":12.736577,"eighty":24.700357,"marketCap":115220716849},{"date":"2025-01-17","current":-15.754836,"twenty":-24.201887,"median":12.665354,"eighty":24.382395,"marketCap":114348600880},{"date":"2025-01-24","current":-16.526091,"twenty":-24.201887,"median":12.629443,"eighty":24.315777,"marketCap":119946368500},{"date":"2025-01-31","current":-16.526091,"twenty":-24.201887,"median":12.589219,"eighty":24.176109,"marketCap":119946368500},{"date":"2025-02-07","current":-16.045454,"twenty":-24.201887,"median":12.557292,"eighty":24.139507,"marketCap":116457904621},{"date":"2025-02-14","current":-12.693406,"twenty":-24.201887,"median":12.48999,"eighty":24.058649,"marketCap":113580593927},{"date":"2025-02-21","current":-12.652584,"twenty":-24.201887,"median":12.441862,"eighty":24.03394,"marketCap":113215317763},{"date":"2025-02-28","current":-13.33522,"twenty":-24.201887,"median":12.405023,"eighty":23.957965,"marketCap":119323546952},{"date":"2025-03-07","current":-13.648189,"twenty":-24.204041,"median":12.35322,"eighty":23.91379,"marketCap":122123997544},{"date":"2025-03-14","current":-13.670868,"twenty":-24.204041,"median":12.333293,"eighty":23.792996,"marketCap":122326928746},{"date":"2025-03-21","current":-13.702619,"twenty":-24.204041,"median":12.308013,"eighty":23.674229,"marketCap":122611032429},{"date":"2025-03-28","current":-13.357899,"twenty":-24.204041,"median":12.274857,"eighty":23.602452,"marketCap":119526478154},{"date":"2025-04-04","current":-13.14819,"twenty":-24.204041,"median":12.234334,"eighty":23.545063,"marketCap":117650007992},{"date":"2025-04-11","current":-11.474536,"twenty":-24.201887,"median":12.193385,"eighty":23.482347,"marketCap":102674150870},{"date":"2025-04-17","current":-11.224398,"twenty":-24.201887,"median":12.165443,"eighty":23.454761,"marketCap":100435911354},{"date":"2025-04-25","current":18.285308,"twenty":-24.204041,"median":12.026806,"eighty":23.356243,"marketCap":99088084638},{"date":"2025-05-02","current":18.63081,"twenty":-24.204041,"median":12.026806,"eighty":23.317376,"marketCap":100960358984},{"date":"2025-05-09","current":17.605571,"twenty":-24.204041,"median":12.026806,"eighty":23.272318,"marketCap":95404588372},{"date":"2025-05-16","current":17.203737,"twenty":-24.204041,"median":12.026806,"eighty":23.222393,"marketCap":93227051906},{"date":"2025-05-23","current":17.661903,"twenty":-24.204041,"median":12.026806,"eighty":23.160274,"marketCap":95709850494},{"date":"2025-05-30","current":17.96985,"twenty":-24.204041,"median":12.026806,"eighty":23.102683,"marketCap":97378616758},{"date":"2025-06-06","current":17.966094,"twenty":-24.204041,"median":12.026806,"eighty":23.03988,"marketCap":97358265950},{"date":"2025-06-13","current":19.036399,"twenty":-24.204041,"median":12.026806,"eighty":23.001392,"marketCap":103158246258},{"date":"2025-06-20","current":17.590549,"twenty":-24.206195,"median":12.014526,"eighty":22.956332,"marketCap":95323185140},{"date":"2025-06-27","current":17.519195,"twenty":-24.206195,"median":12.014526,"eighty":22.892874,"marketCap":94936519786},{"date":"2025-07-03","current":17.620593,"twenty":-24.206195,"median":12.014526,"eighty":22.817575,"marketCap":95485991605},{"date":"2025-07-11","current":18.221465,"twenty":-24.206195,"median":12.014526,"eighty":22.701406,"marketCap":98742120901},{"date":"2025-07-18","current":18.048714,"twenty":-24.206195,"median":12.014526,"eighty":22.649775,"marketCap":97805983728},{"date":"2025-07-25","current":18.379194,"twenty":-24.206195,"median":12.014526,"eighty":22.556783,"marketCap":99596854841},{"date":"2025-08-01","current":17.456793,"twenty":-24.206195,"median":12.014526,"eighty":22.431005,"marketCap":88139349881},{"date":"2025-08-08","current":18.286268,"twenty":-24.177472,"median":12.08226,"eighty":22.400619,"marketCap":92327369611},{"date":"2025-08-15","current":19.273953,"twenty":-24.112846,"median":12.183987,"eighty":22.400619,"marketCap":97314187414},{"date":"2025-08-22","current":19.523897,"twenty":-24.0554,"median":12.220826,"eighty":22.400619,"marketCap":98576157634},{"date":"2025-08-29","current":18.899036,"twenty":-23.982843,"median":12.274273,"eighty":22.400619,"marketCap":95421232085},{"date":"2025-09-05","current":18.82244,"twenty":-23.946253,"median":12.303101,"eighty":22.403337,"marketCap":95034499276},{"date":"2025-09-12","current":19.165106,"twenty":-23.839978,"median":12.319064,"eighty":22.400619,"marketCap":96764619738},{"date":"2025-09-19","current":18.383021,"twenty":-23.674822,"median":12.338712,"eighty":22.400619,"marketCap":92815874212},{"date":"2025-09-26","current":17.500152,"twenty":-23.592711,"median":12.357546,"eighty":22.400619,"marketCap":88358269727},{"date":"2025-10-03","current":18.435429,"twenty":-23.480943,"median":12.407479,"eighty":22.400619,"marketCap":93080480871},{"date":"2025-10-10","current":18.012136,"twenty":-23.373232,"median":12.486069,"eighty":22.400619,"marketCap":90943273241},{"date":"2025-10-17","current":17.49209,"twenty":-23.294244,"median":12.530276,"eighty":22.400619,"marketCap":88317561010},{"date":"2025-10-24","current":17.66947,"twenty":-23.222437,"median":12.579395,"eighty":22.400619,"marketCap":89213152779},{"date":"2025-10-31","current":15.376152,"twenty":-23.143449,"median":12.608867,"eighty":22.400619,"marketCap":92856582929},{"date":"2025-11-07","current":15.71902,"twenty":-22.870582,"median":12.65553,"eighty":22.400619,"marketCap":94927163649},{"date":"2025-11-14","current":16.393222,"twenty":-22.438742,"median":12.730369,"eighty":22.400619,"marketCap":98998669703},{"date":"2025-11-21","current":15.486421,"twenty":-16.752438,"median":12.823604,"eighty":22.400619,"marketCap":93522494060},{"date":"2025-11-28","current":16.58537,"twenty":-16.685372,"median":12.831164,"eighty":22.400619,"marketCap":100159048928},{"date":"2025-12-05","current":17.512398,"twenty":-16.548446,"median":12.905591,"eighty":22.400619,"marketCap":105757369752},{"date":"2025-12-12","current":17.259572,"twenty":-16.520502,"median":12.972348,"eighty":22.400619,"marketCap":104230554982},{"date":"2025-12-19","current":17.977597,"twenty":-16.472997,"median":13.017634,"eighty":22.400619,"marketCap":108566708929},{"date":"2025-12-26","current":18.442797,"twenty":-16.434176,"median":13.073071,"eighty":22.400619,"marketCap":111376048107},{"date":"2026-01-02","current":18.183229,"twenty":-16.414315,"median":13.188985,"eighty":22.400619,"marketCap":109808518276},{"date":"2026-01-09","current":18.843947,"twenty":-16.374704,"median":13.382921,"eighty":22.400619,"marketCap":113798594209},{"date":"2026-01-16","current":19.086659,"twenty":-16.353061,"median":13.69609,"eighty":22.400619,"marketCap":115264336388},{"date":"2026-01-23","current":18.52033,"twenty":-16.325165,"median":14.759881,"eighty":22.400619,"marketCap":111844271303},{"date":"2026-01-30","current":18.297843,"twenty":-16.272473,"median":14.817598,"eighty":22.400619,"marketCap":110500674305},{"date":"2026-02-06","current":17.177207,"twenty":-16.266274,"median":14.914668,"eighty":22.400619,"marketCap":121168020167},{"date":"2026-02-13","current":17.27533,"twenty":-16.266274,"median":15.187513,"eighty":22.400619,"marketCap":121860176196},{"date":"2026-02-20","current":17.408472,"twenty":-16.266274,"median":15.368435,"eighty":22.400619,"marketCap":122799364411},{"date":"2026-02-27","current":17.639431,"twenty":-16.266274,"median":15.435855,"eighty":22.400619,"marketCap":124428543375},{"date":"2026-03-06","current":17.535499,"twenty":-16.266274,"median":15.513389,"eighty":22.400619,"marketCap":123695412841},{"date":"2026-03-13","current":17.01873,"twenty":-16.266274,"median":15.649251,"eighty":22.400619,"marketCap":120050124909},{"date":"2026-03-20","current":16.776224,"twenty":-16.266274,"median":15.733204,"eighty":22.400619,"marketCap":118339486997},{"date":"2026-03-27","current":17.201636,"twenty":-16.266274,"median":15.863974,"eighty":22.400619,"marketCap":121340338090},{"date":"2026-04-02","current":17.867356,"twenty":-16.266274,"median":15.908979,"eighty":22.400619,"marketCap":126036329637},{"date":"2026-04-10","current":17.213213,"twenty":-16.266274,"median":15.985061,"eighty":22.400619,"marketCap":121422007508},{"date":"2026-04-17","current":17.065597,"twenty":-16.266274,"median":16.099944,"eighty":22.400619,"marketCap":120380722426},{"date":"2026-04-24","current":17.082964,"twenty":-16.179488,"median":16.17133,"eighty":22.400619,"marketCap":120503226554},{"date":"2026-05-01","current":17.004639,"twenty":-16.118108,"median":16.242165,"eighty":22.400619,"marketCap":123708751218},{"date":"2026-05-08","current":15.789211,"twenty":-16.03691,"median":16.265124,"eighty":22.400619,"marketCap":114866507643},{"date":"2026-05-15","current":15.935173,"twenty":-15.883379,"median":16.265124,"eighty":22.400619,"marketCap":115928384692},{"date":"2026-05-22","current":16.715511,"twenty":-15.830285,"median":16.286765,"eighty":22.400619,"marketCap":121605342758},{"date":"2026-05-29","current":15.974471,"twenty":-15.759799,"median":16.310377,"eighty":22.403337,"marketCap":116214274666}],"updateTime":1780244766860},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2639601202","title":"Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2639601202","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639601202?lang=en_us&edition=fundamental","pubTime":"2026-05-31 02:15","pubTimestamp":1780164900,"startTime":"0","endTime":"0","summary":"First investigational PD-(L)1xVEGF bispecific immunomodulator to present global datashowingencouraging efficacyin combination with chemotherapyinfirst-linenon-small cell lung canceracrossPD-L1expressi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/30/3303897/0/en/Global-Data-for-BioNTech-and-Bristol-Myers-Squibb-s-PD-L1xVEGF-A-Bispecific-Pumitamig-Shows-Encouraging-Efficacy-in-Patients-with-Non-Small-Cell-Lung-Cancer-in-ROSETTA-Lung-02-Tria.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMS","BK4581","LU0061475181.USD","LU0306806265.USD","LU1093756325.SGD","LU1670710661.SGD","LU1868837136.USD","LU1868837300.USD","LU1883839398.USD","BK4211","IE00BJJMRZ35.SGD","LU0210528500.USD","IE0002141913.USD","L","BK4534","LU0267386448.USD","LU0868494617.USD","BMY","IE00B2B36J28.USD","LU0321505868.SGD","LU0882574055.USD","LU1093756168.USD","BK4559","LU1261432733.SGD","LU2360032135.SGD","BK4195","LU1571399168.USD","LU1430594728.SGD","IE00BFTCPJ56.SGD","LU1670711040.USD","ORR","BK4107","LU0096364046.USD","LU0985481810.HKD","LU0114720955.EUR","BK4532","IE00BFXG1179.USD","IE00BJT1NW94.SGD","LU1868836757.USD","LU2242652126.USD","BK4023","LU1868836591.USD","LU1868836914.USD","LU0225284248.USD","PFS","LU1989771016.USD","LU0321505439.SGD","IE00BSNM7G36.USD","PD","LU0225771236.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639093796","title":"Incyte blood cancer drug combo reduces disease-progression risk but with high side-effect rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2639093796","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639093796?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:00","pubTimestamp":1780142400,"startTime":"0","endTime":"0","summary":"Incyte blood cancer drug combo reduces disease-progression risk but with high side-effect rateMonjuvi combo therapy lowers risk of disease progression in DLBCL trialSevere adverse events and discontinuations higher with Monjuvi combo, but overall death rate lowerIncyte plans to seek expanded US approval for first-line useBy Christy Santhosh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nL4N4261D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","BK4559","LU0306807586.USD","IE00BJJMRZ35.SGD","LU2125154935.USD","LU1670711040.USD","LU0306806265.USD","LU0237698245.USD","LU2360032135.SGD","BMY","LU0321505868.SGD","LU1323610961.USD","LU1670711123.USD","LU1989771016.USD","IE00B2B36J28.USD","LU2125154778.USD","LU1718418525.SGD","LU1983299246.USD","LU0432979614.USD","LU0868494617.USD","LU1093756168.USD","BK4534","LU1670710661.SGD","LU0096364046.USD","LU1074936037.SGD","BK4550","LU0882574055.USD","LU1430594728.SGD","LU1868836591.USD","LU1868836757.USD","LU0456855351.SGD","LU2133065610.SGD","BK4588","LU1571399168.USD","LU1261432733.SGD","LU1868836914.USD","IE0002141913.USD","BK4532","LU1868837136.USD","IE00BJT1NW94.SGD","LU2242652126.USD","LU0114720955.EUR","LU0225284248.USD","LU0985481810.HKD","LU0267386448.USD","BK4007","IE00BFTCPJ56.SGD","LU2242646821.SGD","LU1883839398.USD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639332671","title":"Bloomsbury Publishing (BMY) Receives a Buy from Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2639332671","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639332671?lang=en_us&edition=fundamental","pubTime":"2026-05-30 00:55","pubTimestamp":1780073724,"startTime":"0","endTime":"0","summary":"Deutsche Bank analyst reiterated a Buy rating on Bloomsbury Publishing today and set a price target of p760.00. Currently, the analyst consensus on...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bloomsbury-publishing-bmy-receives-a-buy-from-deutsche-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bloomsbury-publishing-bmy-receives-a-buy-from-deutsche-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4118","LU1670710661.SGD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","LU1868836591.USD","LU0061475181.USD","LU0456855351.SGD","LU0868494617.USD","LU1670711123.USD","IE0009355771.USD","LU1868836757.USD","LU1718418525.SGD","LU2125154778.USD","IE00BFTCPJ56.SGD","LU1670711040.USD","BK4532","LU0306807586.USD","LU0321505868.SGD","LU2133065610.SGD","BK4585","IE0002141913.USD","LU1983299246.USD","LU0225771236.USD","LU2242652126.USD","LU1074936037.SGD","DB","IE00B2B36J28.USD","LU0432979614.USD","LU0985481810.HKD","LU1093756168.USD","LU0096364046.USD","LU1989771016.USD","IE00BJJMRZ35.SGD","LU0114720955.EUR","LU0237698245.USD","LU2125154935.USD","BK4588","BK4559","BMY","LU0306806265.USD","LU1032466523.USD","LU1868837300.USD","LU0267386448.USD","LU1868837136.USD","BK4566","IE00BFXG1179.USD","LU1093756325.SGD","LU1261432733.SGD","LU1430594728.SGD","LU1868836914.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639754679","title":"Bristol-Myers Squibb Backs New Cell Therapy Combo in Early GI Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2639754679","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639754679?lang=en_us&edition=fundamental","pubTime":"2026-05-30 00:34","pubTimestamp":1780072465,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. The Phase 1 study A Phase 1 Study to Evaluate the Safety a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibb-backs-new-cell-therapy-combo-in-early-gi-cancer-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibb-backs-new-cell-therapy-combo-in-early-gi-cancer-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1868837300.USD","IE00BJJMRZ35.SGD","LU2125154935.USD","IE0002141913.USD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","LU0237698245.USD","LU1571399168.USD","LU2360032135.SGD","LU1983299246.USD","LU1718418525.SGD","LU2242652126.USD","LU1323610961.USD","BK4581","LU0882574055.USD","LU0432979614.USD","LU0114720955.EUR","LU1291159041.SGD","LU1868836591.USD","BK4534","LU0225771236.USD","LU1430594728.SGD","LU1868836914.USD","LU1989771016.USD","LU2242646821.SGD","BK4559","BK4532","BMY","LU0096364046.USD","LU0868494617.USD","LU1670711123.USD","LU0321505868.SGD","BK4588","LU0306807586.USD","LU0267386448.USD","LU1883839398.USD","LU0985481810.HKD","LU2125154778.USD","LU1670710588.SGD","IE00BFTCPJ56.SGD","LU1868837136.USD","LU1093756168.USD","LU1670711040.USD","LU1261432733.SGD","IE0009355771.USD","LU1670710661.SGD","LU1585245621.USD","BK4007","LU0225284248.USD","LU2133065610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639391679","title":"C4 Therapeutics jumps after Bristol Myers myeloma data","url":"https://stock-news.laohu8.com/highlight/detail?id=2639391679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639391679?lang=en_us&edition=fundamental","pubTime":"2026-05-29 23:51","pubTimestamp":1780069898,"startTime":"0","endTime":"0","summary":"Shares of C4 Therapeutics (CCCC) are up 19%, or 70c, to $4.36 in midday trading after Bristol Myers (BMY) announced positive Phase 3 multiple myelo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/c4-therapeutics-jumps-after-bristol-myers-myeloma-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/c4-therapeutics-jumps-after-bristol-myers-myeloma-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0321505868.SGD","LU2133065610.SGD","BK4534","LU0456855351.SGD","LU1032466523.USD","LU1670711123.USD","LU0306807586.USD","BK4126","LU0882574055.USD","LU1093756168.USD","LU1983299246.USD","BK4588","BK4559","LU1868837136.USD","LU1883839398.USD","LU1430594728.SGD","LU2360032135.SGD","LU0225771236.USD","LU1074936037.SGD","LU1718418525.SGD","LU1261432733.SGD","LU2242652126.USD","LU1323610961.USD","MYE","LU1585245621.USD","LU0985481810.HKD","LU1571399168.USD","BK4581","LU1093756325.SGD","CCCC","LU1868836914.USD","LU0096364046.USD","LU1868836757.USD","LU0321505439.SGD","LU0267386448.USD","LU0432979614.USD","LU1291159041.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU1670710588.SGD","LU1670711040.USD","BMY","LU2242646821.SGD","LU0114720955.EUR","BK4007","IE0009355771.USD","IE00BSNM7G36.USD","BK4532","IE0002141913.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639397673","title":"Jefferies Adjusts Price Target on Bristol-Myers Squibb to $73 From $70, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2639397673","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639397673?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:07","pubTimestamp":1780063637,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb (BMY) has an average rating of overweight and mean price target of $63.26, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639040620","title":"Bristol Myers says CELMoD mezigdomide reduces risk of disease progression by 52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639040620","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639040620?lang=en_us&edition=fundamental","pubTime":"2026-05-29 21:14","pubTimestamp":1780060453,"startTime":"0","endTime":"0","summary":"Bristol Myers (BMY) Squibb announced late-breaking results from the Phase 3 SUCCESSOR-2 trial of CELMoD mezigdomide in combination with carfilzomib...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-says-celmod-mezigdomide-reduces-risk-of-disease-progression-by-52-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-says-celmod-mezigdomide-reduces-risk-of-disease-progression-by-52-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0225771236.USD","LU1261432733.SGD","LU2242646821.SGD","IE00BFTCPJ56.SGD","LU0985481810.HKD","IE00B2B36J28.USD","LU0432979614.USD","LU1670711040.USD","LU0225284248.USD","LU1868836591.USD","MYE","IE00BJJMRZ35.SGD","LU0306807586.USD","LU1571399168.USD","LU1670710588.SGD","LU2360032135.SGD","LU1883839398.USD","LU0306806265.USD","LU1868836757.USD","LU0321505868.SGD","LU2125154935.USD","IE0002141913.USD","LU1989771016.USD","IE0009355771.USD","BK4585","LU0882574055.USD","BMY","LU0114720955.EUR","LU1868837136.USD","BK4559","LU1983299246.USD","IE00BSNM7G36.USD","LU2242652126.USD","LU1093756168.USD","BK4126","LU0267386448.USD","LU0061475181.USD","LU1323610961.USD","LU1430594728.SGD","LU1718418525.SGD","LU1868836914.USD","BK4581","BK4534","LU1032466523.USD","LU1291159041.SGD","LU0096364046.USD","BK4007","BK4532","LU0868494617.USD","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639367620","title":"Bristol-Myers Squibb Says Mezigdomide Combination Cuts Myeloma Progression Risk in Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2639367620","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639367620?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:56","pubTimestamp":1780059396,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb  said Friday a phase 3 trial showed that its oral cereblon E3 ligase modulation, or CELMoD, agent mezigdomide combined with carfilzomib and dexamethasone lowered by 52% the risk of disease progression or death in patients with relapsed or refractory multiple myeloma.The investigational combination therapy extended progression-free survival to 18 months, compared with 8.3 months for individuals receiving only carfilzomib and dexamethasone, the company said.The experimental group also registered higher overall response and complete response rates at 80.2% and 26.7%, compared with 53.4% and 8.9% for participants receiving standard of care, Bristol-Myers Squibb said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0985481810.HKD","LU1291159041.SGD","LU2242646821.SGD","LU1868836914.USD","LU1883839398.USD","LU0225771236.USD","LU1074936037.SGD","LU1670710661.SGD","BK4534","LU0321505439.SGD","IE00B2B36J28.USD","LU1323610961.USD","IE00BFXG1179.USD","BMY","LU0432979614.USD","LU1868836591.USD","BK4581","LU1983299246.USD","IE00BFTCPJ56.SGD","LU2360032135.SGD","LU1868837300.USD","LU0267386448.USD","LU1093756325.SGD","BK4585","BK4588","LU1430594728.SGD","LU0882574055.USD","LU0456855351.SGD","LU2125154778.USD","LU1670711040.USD","BK4532","IE00BJT1NW94.SGD","LU1670711123.USD","LU2242652126.USD","LU0306807586.USD","LU1032466523.USD","LU0306806265.USD","LU0114720955.EUR","LU1585245621.USD","LU0061475181.USD","LU0321505868.SGD","IE00BSNM7G36.USD","LU1718418525.SGD","IE0002141913.USD","LU1670710588.SGD","LU1989771016.USD","IE00BJJMRZ35.SGD","LU0868494617.USD","LU1868836757.USD","LU1261432733.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639062295","title":"Bristol Myers Squibb Announces Celmod Mezigdomide Reduces Risk of Disease Progression or Death by More Than 50% VS. Standard of Care in Relapsed or Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2639062295","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639062295?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nTUA7D1RVY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2242646821.SGD","IE00BJT1NW94.SGD","LU0882574055.USD","IE00BFTCPJ56.SGD","LU1430594728.SGD","LU1670710661.SGD","LU1670711040.USD","LU2360032135.SGD","BMY","BK4534","LU1868836914.USD","IE0009355771.USD","LU1989771016.USD","LU2125154778.USD","IE00BJJMRZ35.SGD","LU0267386448.USD","LU1983299246.USD","LU1323610961.USD","BK4581","LU1868837136.USD","LU0225284248.USD","LU2242652126.USD","BK4007","LU1868836757.USD","IE00B2B36J28.USD","LU0306806265.USD","LU1032466523.USD","LU1868836591.USD","LU0096364046.USD","LU1868837300.USD","LU2125154935.USD","IE00BSNM7G36.USD","LU0321505439.SGD","LU1670711123.USD","BK4559","LU0306807586.USD","LU1093756168.USD","LU0456855351.SGD","BK4588","LU0321505868.SGD","LU0225771236.USD","LU0868494617.USD","LU1261432733.SGD","IE0002141913.USD","LU0237698245.USD","LU0432979614.USD","LU1093756325.SGD","LU1718418525.SGD","LU1670710588.SGD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639955622","title":"Bristol Myers Squibb: Mezikd Reduces Disease Progression/Death Risk by Over 50% VS Standard of Care in Relapsed or Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2639955622","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639955622?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nP8N3S504Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","LU1868836914.USD","LU2242646821.SGD","LU0225771236.USD","LU1074936037.SGD","LU1670710661.SGD","BK4534","LU0321505439.SGD","IE00B2B36J28.USD","LU1323610961.USD","BMY","LU0432979614.USD","LU1868836591.USD","BK4581","LU1983299246.USD","IE00BFTCPJ56.SGD","LU1868837136.USD","LU2360032135.SGD","LU0225284248.USD","LU1868837300.USD","BK4007","LU0267386448.USD","LU1093756325.SGD","BK4588","LU1430594728.SGD","LU0882574055.USD","LU0456855351.SGD","LU2125154778.USD","LU1670711040.USD","LU1670711123.USD","IE00BJT1NW94.SGD","LU2242652126.USD","LU0306807586.USD","LU1032466523.USD","LU0306806265.USD","LU0096364046.USD","LU2125154935.USD","LU0321505868.SGD","IE00BSNM7G36.USD","LU1718418525.SGD","IE0002141913.USD","LU1093756168.USD","LU1670710588.SGD","LU1989771016.USD","IE00BJJMRZ35.SGD","LU0237698245.USD","BK4559","LU0868494617.USD","LU1868836757.USD","LU1261432733.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639662295","title":"Bristol Myers Squibb: Higher Overall Response Rate and Complete Response or Better Were Seen With Mezikd","url":"https://stock-news.laohu8.com/highlight/detail?id=2639662295","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639662295?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nP8N3S504Y:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4534","LU0267386448.USD","LU0321505439.SGD","BK4585","LU1983299246.USD","IE00BFXG1179.USD","LU0237698245.USD","LU1093756325.SGD","BK4532","IE00BSNM7G36.USD","LU0868494617.USD","LU0456855351.SGD","LU0225771236.USD","LU1868836591.USD","LU1883839398.USD","IE00BJT1NW94.SGD","BK4559","LU2242646821.SGD","LU1718418525.SGD","IE0002141913.USD","LU1571399168.USD","LU1261432733.SGD","LU1670711123.USD","IE0009355771.USD","LU1989771016.USD","LU1585245621.USD","LU1074936037.SGD","LU2360032135.SGD","LU0306806265.USD","LU0432979614.USD","LU1093756168.USD","LU1670711040.USD","BMY","BK4007","LU1868837300.USD","LU2242652126.USD","LU0985481810.HKD","LU1868836757.USD","LU2133065610.SGD","LU1430594728.SGD","BK4581","IE00BFTCPJ56.SGD","LU1868837136.USD","LU0321505868.SGD","IE00BJJMRZ35.SGD","LU1323610961.USD","LU0096364046.USD","LU0225284248.USD","LU1868836914.USD","LU2125154778.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639622953","title":"Bristol Myers Squibb: Safety Profile of Mezikd Was Consistent With Known Profile of Mezigdomide & Combination Regimen","url":"https://stock-news.laohu8.com/highlight/detail?id=2639622953","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639622953?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nP8N3S504Y:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0306806265.USD","LU1718418525.SGD","IE00BFXG1179.USD","LU1585245621.USD","LU1670711123.USD","LU1868836914.USD","LU0096364046.USD","LU1983299246.USD","LU2125154935.USD","BK4581","LU1032466523.USD","LU1074936037.SGD","LU1093756325.SGD","BK4007","LU0321505868.SGD","LU0114720955.EUR","LU0321505439.SGD","LU1571399168.USD","LU2242646821.SGD","BK4559","LU0306807586.USD","LU1868837300.USD","LU0868494617.USD","LU0061475181.USD","LU2242652126.USD","LU2133065610.SGD","IE00B2B36J28.USD","LU0225771236.USD","LU0267386448.USD","BK4532","LU0237698245.USD","LU1670710661.SGD","LU0432979614.USD","LU1093756168.USD","LU0225284248.USD","LU1670711040.USD","LU0456855351.SGD","LU0882574055.USD","LU1868836591.USD","LU1868836757.USD","BK4534","IE00BSNM7G36.USD","LU1291159041.SGD","BK4588","LU1430594728.SGD","LU1323610961.USD","IE00BJJMRZ35.SGD","BMY","LU1261432733.SGD","LU1868837136.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639622935","title":"Bristol Myers Squibb: Significantly Improved Pfs Rates With Mezikd Across Patients in Second- & Third-Line and Those With Higher-Risk Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2639622935","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639622935?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nP8N3S504Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0985481810.HKD","BMY","IE00BJT1NW94.SGD","LU0114720955.EUR","IE00B2B36J28.USD","BK4588","IE00BFTCPJ56.SGD","LU1718418525.SGD","LU1868836914.USD","LU0225284248.USD","LU0321505439.SGD","IE00BJJMRZ35.SGD","LU1670710661.SGD","LU1093756325.SGD","BK4581","LU2133065610.SGD","LU0061475181.USD","LU0237698245.USD","LU0225771236.USD","BK4007","LU1032466523.USD","LU1670711040.USD","LU1989771016.USD","LU0096364046.USD","LU2242646821.SGD","LU0321505868.SGD","LU1883839398.USD","LU0267386448.USD","LU1585245621.USD","BK4532","LU1261432733.SGD","LU0456855351.SGD","LU1670710588.SGD","LU1868836591.USD","LU1291159041.SGD","LU1323610961.USD","BK4534","IE0002141913.USD","LU2125154778.USD","LU0882574055.USD","LU1670711123.USD","BK4585","LU2360032135.SGD","IE00BSNM7G36.USD","LU0306807586.USD","LU1868836757.USD","IE00BFXG1179.USD","LU0432979614.USD","LU0868494617.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639229546","title":"Bristol Myers Squibb: Phase 3 Successor-2 Trial Shows Mezikd Achieves 18-Month Median Pfs","url":"https://stock-news.laohu8.com/highlight/detail?id=2639229546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639229546?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nP8N3S504Y:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0306806265.USD","BK4585","LU0868494617.USD","LU1989771016.USD","LU1323610961.USD","LU2360032135.SGD","LU0267386448.USD","BMY","LU1430594728.SGD","IE00BFXG1179.USD","BK4559","LU1868836914.USD","LU1868837300.USD","LU1718418525.SGD","BK4581","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU1585245621.USD","IE00BSNM7G36.USD","LU0306807586.USD","IE0002141913.USD","BK4534","LU1670710661.SGD","LU1868836591.USD","LU1093756168.USD","LU0225771236.USD","LU1261432733.SGD","LU1983299246.USD","LU1032466523.USD","LU1883839398.USD","LU2133065610.SGD","LU2242646821.SGD","LU1093756325.SGD","BK4588","LU1868837136.USD","LU2125154778.USD","LU1291159041.SGD","LU0456855351.SGD","LU2242652126.USD","IE00BFTCPJ56.SGD","LU0096364046.USD","LU0061475181.USD","LU0225284248.USD","IE00BJT1NW94.SGD","LU1571399168.USD","LU1670711040.USD","LU0114720955.EUR","BK4007","LU1868836757.USD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639221516","title":"Bristol Myers drug delays myeloma progression in hard to treat patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2639221516","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639221516?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056000,"startTime":"0","endTime":"0","summary":"Bristol Myers drug delays myeloma progression in hard to treat patientsBy Michael ErmanMay 29 (Reuters) - Bristol Myers Squibb BMY.N said on Friday that its experimental oral drug mezigdomide delayed ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL1N42511A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","LU0267386448.USD","LU0320765992.SGD","LU1061106388.HKD","BK4588","LU1718418525.SGD","BK4533","BK4599","LU1989771016.USD","LU1868837300.USD","BK4139","LU0289739699.SGD","LU0889565916.HKD","LU1868836591.USD","LU1023059063.AUD","LU0985481810.HKD","LU1057294990.SGD","IE00B2B36J28.USD","SG9999001440.SGD","LU2360032135.SGD","BK4559","BK4585","LU0882574055.USD","BK4566","LU1868836757.USD","LU0114720955.EUR","LU2242646821.SGD","LU0225771236.USD","AMGN","LU1032466523.USD","BMY","LU0321505439.SGD","LU1670710661.SGD","LU0321505868.SGD","LU1093756325.SGD","LU0306807586.USD","LU1291159041.SGD","LU0122379950.USD","IE0002141913.USD","LU1261432733.SGD","LU1571399168.USD","LU1983299246.USD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","LU0225284248.USD","LU1323610961.USD","LU1883839398.USD","LU1430594728.SGD","LU0061475181.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639629902","title":"Bristol-Myers Squibb: Hold Rating Reiterated as Analyst Maintains $61 Price Target Amid Near-Term Uncertainties and Long-Term Pipeline Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2639629902","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639629902?lang=en_us&edition=fundamental","pubTime":"2026-05-29 18:16","pubTimestamp":1780049774,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Asad Haider from Goldman Sachs maint...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/bristol-myers-squibb-hold-rating-reiterated-as-analyst-maintains-61-price-target-amid-near-term-uncertainties-and-long-term-pipeline-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/bristol-myers-squibb-hold-rating-reiterated-as-analyst-maintains-61-price-target-amid-near-term-uncertainties-and-long-term-pipeline-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639986640","title":"Bayer's Key Pharma Products Face Competitive Risk -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2639986640","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639986640?lang=en_us&edition=fundamental","pubTime":"2026-05-29 16:15","pubTimestamp":1780042500,"startTime":"0","endTime":"0","summary":"0815 GMT - Bayer's pharmaceutical business has good momentum but faces risks over the medium term from potential competition to key products like its Kerendia kidney drug and asundexian for stroke prevention, Jefferies analysts say. The German group's pharma division should deliver annual sales growth of 2% over the 2025-2030 period, compared with the average growth rate of 5% among peers, according to Jefferies. Asundexian's potential market is a lot smaller after a trial for a type of heart arrhythmia known as atrial fibrillation failed and Bristol Myers Squibb's rival treatment milvexian could have an edge, they add. For Bayer's Kerendia, momentum is good for now, but the threat of competition looms on the horizon with AstraZeneca and Mineralys Therapeutics developing a new class of drugs, Jefferies says. Bayer shares fall 1.3%. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","LU1670710661.SGD","LU0058720904.USD","LU0306806265.USD","AZNH","LU1868837300.USD","IE00BFXG1179.USD","BK4139","LU1571399168.USD","LU1989771016.USD","LU2237443895.HKD","LU1829250122.USD","LU2462157665.USD","LU1868836757.USD","LU0225284248.USD","LU2125154935.USD","LU2237443622.USD","LU1323610961.USD","BK4568","LU1718418525.SGD","LU2360032135.SGD","LU2456880835.USD","LU1670711123.USD","LU2237443382.USD","LU0289739699.SGD","LU0456855351.SGD","LU0321505868.SGD","LU0061475181.USD","LU2125154778.USD","LU1430594728.SGD","LU0889565916.HKD","LU0882574055.USD","LU1670710588.SGD","IE00BJT1NW94.SGD","BK4532","LU2242652126.USD","IE00BJJMRZ35.SGD","BAYRY","LU0432979614.USD","IE0009355771.USD","LU1585245621.USD","LU1291159041.SGD","AZN","LU0225771236.USD","IE0002141913.USD","LU2242646821.SGD","BK4007","LU1074936037.SGD","MLYS","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639648182","title":"Capricor names Michael Maurer chief commercial officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2639648182","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639648182?lang=en_us&edition=fundamental","pubTime":"2026-05-29 09:58","pubTimestamp":1780019939,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics appointed Michael Maurer as chief commercial officer, effective immediately, to strengthen launch readiness for Deramiocel in Duchenne muscular dystrophy.Maurer brings about two decades in rare-disease commercialization, patient access, and launch strategy, including work at Amicus Therapeutics, Sarepta Therapeutics, and Bristol Myers Squibb.At Sarepta, he led the U.S. launch of ELEVIDYS for Duchenne muscular dystrophy, shaping commercial strategy for the company’s approved RNA therapies.He will run the global commercial organization, covering market access, patient support, distribution strategy, and operational planning ahead of an Aug. 22, 2026 PDUFA date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capricor","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL68QMpR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","LU1261432733.SGD","IE00BFTCPJ56.SGD","LU0985481810.HKD","CAPR","LU0432979614.USD","LU0225284248.USD","LU1670711123.USD","IE00BJJMRZ35.SGD","LU0306807586.USD","LU1571399168.USD","LU1670710588.SGD","IE00BJT1NW94.SGD","IE00B19Z3581.USD","LU1883839398.USD","BK4566","LU0306806265.USD","LU0237698245.USD","LU1868836757.USD","LU2133065610.SGD","LU0321505868.SGD","LU1585245621.USD","LU2125154935.USD","IE0002141913.USD","LU1989771016.USD","BK4585","LU0882574055.USD","BK4139","IE00B19Z3B42.SGD","BMY","LU0114720955.EUR","BK4588","BMRN","BK4559","LU0321505439.SGD","LU1983299246.USD","LU2242652126.USD","LU1093756168.USD","LU0267386448.USD","LU2125154778.USD","LU0061475181.USD","LU1323610961.USD","LU1718418525.SGD","LU1868836914.USD","BK4581","LU0456855351.SGD","LU0096364046.USD","BK4532","LU1868837300.USD","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639619575","title":"Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2639619575","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639619575?lang=en_us&edition=fundamental","pubTime":"2026-05-29 04:38","pubTimestamp":1780000680,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  shed 1.06% to $56.91 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.58% to 7,563.63 and the Dow Jones Industrial Average  rising 0.05% to 50,668.97.This was the stock's fourth consecutive day of losses.Bristol Myers Squibb Co. closed 9.50% short of its 52-week high of $62.89, which the company reached on March 2nd.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 0.21% to $230.80, Pfizer Inc.  fell 0.27% to $26.14, and Abbott Laboratories  rose 0.72% to $86.30.Trading volume  eclipsed its 50-day average volume of 11.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 28, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306806265.USD","BK4585","LU0868494617.USD","LU1989771016.USD","LU0237698245.USD","LU0985481810.HKD","LU1323610961.USD","LU2360032135.SGD","LU0267386448.USD","BMY","LU1430594728.SGD","LU0432979614.USD","IE00BFXG1179.USD","BK4559","LU0321505868.SGD","LU1868836914.USD","LU1868837300.USD","LU1718418525.SGD","BK4581","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU1585245621.USD","IE00BSNM7G36.USD","LU0306807586.USD","IE0002141913.USD","LU1670710588.SGD","BK4534","LU1670710661.SGD","LU1868836591.USD","LU1093756168.USD","LU0225771236.USD","LU1261432733.SGD","LU1983299246.USD","LU1032466523.USD","LU1883839398.USD","LU2133065610.SGD","IE0009355771.USD","LU2242646821.SGD","LU1093756325.SGD","BK4588","LU1868837136.USD","BK4532","LU2125154778.USD","LU1291159041.SGD","LU1670711123.USD","LU0456855351.SGD","LU2242652126.USD","IE00BFTCPJ56.SGD","LU0096364046.USD","LU0061475181.USD","LU0882574055.USD","LU2125154935.USD","LU0225284248.USD","IE00BJT1NW94.SGD","LU0321505439.SGD","LU1571399168.USD","LU1670711040.USD","LU0114720955.EUR","BK4007","LU1868836757.USD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698274","title":"Alto Neuroscience names Karuna Therapeutics founder Andrew Miller to board","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698274","media":"Reuters","labels":["executive","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638698274?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:07","pubTimestamp":1779970072,"startTime":"0","endTime":"0","summary":"Alto Neuroscience named Andrew Miller to its board, effective May 27, 2026.Miller founded Karuna Therapeutics. He led R&D. He also served as CEO and COO. Karuna sold to Bristol Myers Squibb for $14 billion in 2024.He was lead inventor of KarXT, now marketed by Bristol Myers Squibb as COBENFY for schizophrenia.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL6TYBPP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","LU0061475181.USD","LU2360032135.SGD","LU2133065610.SGD","LU1323610961.USD","LU0868494617.USD","LU1261432733.SGD","LU1571399168.USD","LU1868837300.USD","BK4588","LU1718418525.SGD","BK4007","LU1670710661.SGD","LU0225284248.USD","LU0432979614.USD","LU2125154935.USD","LU1868836914.USD","LU0237698245.USD","LU0225771236.USD","LU0882574055.USD","LU1032466523.USD","BK4559","BK4585","LU0321505439.SGD","LU1074936037.SGD","LU0306807586.USD","IE00BJJMRZ35.SGD","LU1585245621.USD","LU1670711040.USD","LU0321505868.SGD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU0306806265.USD","LU2125154778.USD","LU2242652126.USD","BMY","ANRO","LU1670711123.USD","IE00BSNM7G36.USD","LU1670710588.SGD","LU1883839398.USD","LU1093756168.USD","IE0009355771.USD","LU1868836591.USD","LU0985481810.HKD","BK4534","LU0267386448.USD","LU1989771016.USD","BK4581","LU1868836757.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}